RxDoctor Payments Data

Dilip Solanki

Hematology & Oncology · Dallas, TXNPI 1124060116

Payments from drug & device makers

$16,197in general payments, 2019–2025

Across 108 payments — averaging $149.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$5K
  • Kyowa Kirin, Inc.$5K
  • Seagen Inc.$2K
  • Merck$432
  • Johnson & Johnson$429
  • AstraZeneca$391
  • plus $4K from 29 others

What the payments were for

  • Consulting fees$7,46046%
  • Speaking & faculty fees$1,5009%
  • Travel & lodging$1,79811%
  • Food & beverage$5,24032%
  • Education$1981%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,197 in reported general payments places this provider in the 55th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Other hematology & oncology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →